Vigilant Capital Management
AGN

Vigilant Capital Management’s Allergan Inc AGN Stock Holding History

Vigilant Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,500
Closed -$408K – 302
2015
Q3 		$408K Hold
1,500
– – 0.08% 83
2015
Q2 		$455K Buy
+1,500
New +$455K 0.08% 85
2014
Q1 		– Sell
-300
Closed -$33K – 295
2013
Q4 		$33K Hold
300
– – 0.01% 178
2013
Q3 		$27K Hold
300
– – 0.01% 167
2013
Q2 		$25K Buy
+300
New +$31.1K 0.01% 175

Other funds holding AGN

Summitry LLC
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
III
Independent Investors Inc Nesconset, New York $524M AUM 29.67% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Mitchell McLeod Pugh & Williams
Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
Dowling & Yahnke
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
Henry H. Armstrong Associates
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.12B AUM 9.9% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $116M AUM 2.72% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Vigilant Capital Management's AGN Position: Q4 2015 in Review

Vigilant Capital Management sold out of Allergan Inc (AGN) in Q4 2015, closing a stake of 1,500 shares — an estimated $408K sold.

Vigilant Capital Management first reported a position in AGN in Q2 2013 and held it in 5 quarters. The position peaked at $455K in Q2 2015. 28 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Vigilant Capital Management reported no remaining Allergan Inc position as of Q4 2015 after selling out during the quarter.
  • Vigilant Capital Management sold 1,500 Allergan Inc shares in Q4 2015, an estimated $408K.
  • Vigilant Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 5 quarters.
  • Vigilant Capital Management's Allergan Inc position peaked at $455K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2015.

Based on Vigilant Capital Management's 13F filing for Q4 2015, filed 26 Jan 2016.